President Donald Trump on Monday made a sweeping promise to bring down drug prices and stop pharma companies from taking ...

White House drug pricing plan faces skepticism as experts question feasibility of Trump's executive order to align US prices ...

Roche said its $50 billion promise to expand its manufacturing footprint in the US has the potential to be 'reassessed.' ...

House tax bill includes PBM reforms, spread pricing restrictions & orphan drug negotiation changes, with Rep. Guthrie leading ...

Stylus Medicine, a startup founded by Patrick Hsu, has raised $85 million to develop a suite of technologies that it believes ...

Vir Biotech's hepatitis B therapy shows 4% cure rate with doublet (tobevibart/elebsiran) and 10% with triplet therapy, below ...

The White House outlined plans to force down prices of drugs sold in the US using the threat of tying costs to rates paid by ...

New data shows Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy in weight loss, with 65% vs 40% of patients achieving ...

FDA clears Ensoma's trial of in vivo blood stem cell editing therapy for X-linked chronic granulomatous disease, following China's Yoltech earlier this year.

The AI-fo­cused biotech in­sitro has laid off 22% of its work­force, the com­pa­ny said in a Thurs­day state­ment. Found­ed ...

Vinay Prasad named to replace Peter Marks as head of FDA's Center for Biologics Evaluation and Research; discussion planned ...

After working off $20 million in seed funding for about four years, HAYA Therapeutics tapped the funding well and came back ...